Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADC Therapeutics SA | 80,000 | reported | 03 Jun 2025 | tx 2+120,000 |
| aTYR PHARMA INC | 50,000 | reported | 11 May 2026 | tx 12+206,856−12,000 |
| FATE THERAPEUTICS INC | 40,000 | reported | 07 Jun 2024 | tx 8+123,558−1,439 |
| Travere Therapeutics, Inc. | 12,000 | reported | 19 May 2026 | tx 20+140,000−39,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 15 May 2026 | SALE | Travere Therapeutics, Inc. | 3,250 | 43.49 USD | 10b5-1 |
| 11 May 2026 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 31 Oct 2025 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 17.44 USD | |
| 31 Oct 2025 | SALE | Travere Therapeutics, Inc. | 18,000 | 35.03 USD | |
| 31 Oct 2025 | EXERCISE | Travere Therapeutics, Inc. | 8,000 | 16.33 USD | |
| 31 Oct 2025 | EXERCISE | Travere Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 31 Oct 2025 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | ADC Therapeutics SA | 40,000 | 0.00 USD | |
| 03 Jun 2025 | GRANT_AWARD | ADC Therapeutics SA | 80,000 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 6,500 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | FATE THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 30 May 2024 | PURCHASE | aTYR PHARMA INC | 50,000 | 1.75 USD | |
| 22 May 2024 | GRANT_AWARD | aTYR PHARMA INC | 24,000 | 0.00 USD | deriv |
| 08 May 2024 | GRANT_AWARD | Travere Therapeutics, Inc. | 6,500 | 0.00 USD | |
| 08 May 2024 | GRANT_AWARD | Travere Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | FATE THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,500 | 0.00 USD | |
| 17 May 2023 | GRANT_AWARD | Travere Therapeutics, Inc. | 13,500 | 0.00 USD | deriv |
| 17 May 2023 | GIFT | aTYR PHARMA INC | 6,000 | 0.00 USD | |
| 17 May 2023 | GIFT | aTYR PHARMA INC | 6,000 | 0.00 USD | |
| 17 May 2023 | GRANT_AWARD | aTYR PHARMA INC | 12,000 | 0.00 USD | deriv |